Form 4: Becton Dickinson Director Christopher Jones Reports Acquisition of Rights to Common Stock
SEC Form 4 Filing
Director Christopher Ian Montague Jones reports acquiring rights to 128 shares of Becton Dickinson common stock under the Deferred Compensation Plan.
Summary
- Christopher Ian Montague Jones, a director of Becton Dickinson & Co (BDX), filed a Form 4 on November 5, 2024, reporting a transaction.
- The transaction involves the acquisition of rights to 128 shares of common stock under the Becton Dickinson Deferred Compensation Plan.
- These rights convert to common stock on a one-for-one basis and are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.
- The price of the rights is $233.59.
- Following the reported transaction, Jones beneficially owns 10,392 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Future Outlook
The rights to common stock will be distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 11/05/2024 | Date of the transaction: acquisition of rights to common stock under the Deferred Compensation Plan. |
| 11/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.